DiaMedica Therapeutics Inc. ( DMAC) - Stock Earnings
DMAC Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | -8.6 million USD | — USD |
| 2025Q4 | -8.7 million USD | -27999 USD |
| 2026Q1 | -10.0 million USD | — USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
DMAC Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -19.4 million USD | — USD |
| 2024 | -24.4 million USD | — USD |
| 2025 | -32.8 million USD | — USD |
| 2026 Est. | — | — |
DMAC
Price: $5.88
52 week price:
Earnings Per Share: -0.71 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 67400
Market Capitalization: 303.9 million